• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT SYPHILIS TP REAGENT KIT; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT SYPHILIS TP REAGENT KIT; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM Back to Search Results
Catalog Number 08D06-77
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/09/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 08d06-77 that has a similar product distributed in the us, list number 8d06-31.
 
Event Description
The customer generated a false negative architect (b)(6) tp result for one patient.The following information was provided: on (b)(6) 2020 sid (b)(6) initial result 0.49s/co, retest 0.52s/co and 0.53s/co; tppa positive the patient is a (b)(6) year old male being diagnosed with a rash.No impact to patient management was reported.
 
Manufacturer Narrative
H6 health effect impact code: f26 component code: g01003 d8 was this device serviced by a third party? unknown a review of tickets was performed for reagent lot number 12693be01.The ticket search determined that there is normal complaint activity for the reagent lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing completed and the following results were obtained: architect syphilis tp: 0.49 s/co (non-reactive) recomline treponema igm: negative recomline treponema igg: negative a retained reagent kit of lot number 12693be01 was tested in a specificity setup.Results of this setup did not implicate that the performance regarding specificity of the lot is negatively impacted as no false nonreactive results were obtained.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.A review of labeling concluded that the issue is sufficiently addressed.Based on the investigation no systemic issue or deficiency of the architect syphilis tp reagent lot number 12693be01 was identified.Section d: suspect medical device lot number is corrected to 12693be01.
 
Manufacturer Narrative
This follow up is submitted to populate fields d8 and/or h6 with data that had previously been provided in field h10.There is no change to the content of the data.
 
Manufacturer Narrative
Previous versions of this report included a date populated in d9.This date was erroneously populated into d9 and has been removed.
 
Manufacturer Narrative
Section d: suspect medical device lot number is corrected to 12693be01.
 
Manufacturer Narrative
Section d: suspect medical device lot number is corrected to 12693be01.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT SYPHILIS TP REAGENT KIT
Type of Device
ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key11039600
MDR Text Key241307310
Report Number3002809144-2020-01196
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
PMA/PMN Number
K153730
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 08/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/02/2021
Device Catalogue Number08D06-77
Device Lot Number12693BE01
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer01/18/2021
Initial Date Manufacturer Received 12/09/2020
Initial Date FDA Received12/18/2020
Supplement Dates Manufacturer Received02/24/2021
06/20/2021
06/28/2021
07/22/2021
08/17/2021
Supplement Dates FDA Received03/15/2021
06/22/2021
07/01/2021
07/22/2021
08/20/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6)
Patient Age6 YR
-
-